EWS/FLI1 regulates EYA3 in Ewing sarcoma via modulation of miRNA-708, resulting in increased cell survival and chemoresistance.

PubWeight™: 1.04‹?› | Rank: Top 15%

🔗 View Article (PMC 3432289)

Published in Mol Cancer Res on June 20, 2012

Authors

Tyler P Robin1, Anna Smith, Erin McKinsey, Lisa Reaves, Paul Jedlicka, Heide L Ford

Author Affiliations

1: Department of Pharmacology, University of Colorado School of Medicine, Aurora, CO 80045, USA.

Articles citing this

Dual targeting of EWS-FLI1 activity and the associated DNA damage response with trabectedin and SN38 synergistically inhibits Ewing sarcoma cell growth. Clin Cancer Res (2013) 1.80

Molecular mechanisms of ETS transcription factor-mediated tumorigenesis. Crit Rev Biochem Mol Biol (2013) 1.08

MicroRNA function and dysregulation in bone tumors: the evidence to date. Cancer Manag Res (2014) 1.07

MicroRNAs: novel players in cancer diagnosis and therapies. Biomed Res Int (2014) 1.05

The SIX1-EYA transcriptional complex as a therapeutic target in cancer. Expert Opin Ther Targets (2015) 0.94

Glucocorticoids mediate induction of microRNA-708 to suppress ovarian cancer metastasis through targeting Rap1B. Nat Commun (2015) 0.92

MicroRNAs in Ewing Sarcoma. Front Oncol (2013) 0.90

Understanding the Biology of Bone Sarcoma from Early Initiating Events through Late Events in Metastasis and Disease Progression. Front Oncol (2013) 0.88

let-7b suppresses apoptosis and autophagy of human mesenchymal stem cells transplanted into ischemia/reperfusion injured heart 7by targeting caspase-3. Stem Cell Res Ther (2015) 0.85

Twenty Years on: What Do We Really Know about Ewing Sarcoma and What Is the Path Forward? Crit Rev Oncog (2015) 0.85

Differentially expressed miRNAs in Ewing sarcoma compared to mesenchymal stem cells: low miR-31 expression with effects on proliferation and invasion. PLoS One (2014) 0.84

MAPK target sites of eyes absent are not required for eye development or survival in Drosophila. PLoS One (2012) 0.83

Sequencing Overview of Ewing Sarcoma: A Journey across Genomic, Epigenomic and Transcriptomic Landscapes. Int J Mol Sci (2015) 0.82

Eyes absent tyrosine phosphatase activity is not required for Drosophila development or survival. PLoS One (2013) 0.82

Post-transcriptional controls by ribonucleoprotein complexes in the acquisition of drug resistance. Int J Mol Sci (2013) 0.80

Structure-activity relationships of benzbromarone metabolites and derivatives as EYA inhibitory anti-angiogenic agents. PLoS One (2013) 0.79

MicroRNAs in soft tissue sarcomas: overview of the accumulating evidence and importance as novel biomarkers. Biomed Res Int (2014) 0.79

Membrane expression of MRP-1, but not MRP-1 splicing or Pgp expression, predicts survival in patients with ESFT. Br J Cancer (2013) 0.77

Induction of the mesenchymal to epithelial transition by demethylation-activated microRNA-125b is involved in the anti-migration/invasion effects of arsenic trioxide on human chondrosarcoma. J Exp Clin Cancer Res (2016) 0.76

What Do We Know about the Role of miRNAs in Pediatric Sarcoma? Int J Mol Sci (2015) 0.76

MicroRNA-708-5p acts as a therapeutic agent against metastatic lung cancer. Oncotarget (2016) 0.76

Mechanisms of doxorubicin resistance in hepatocellular carcinoma. Hepat Oncol (2016) 0.75

Biomarkers of Osteosarcoma, Chondrosarcoma, and Ewing Sarcoma. Front Pharmacol (2017) 0.75

Hsa-let-7c-5p augments enterovirus 71 replication through viral subversion of cell signaling in rhabdomyosarcoma cells. Cell Biosci (2017) 0.75

Malignant round cell tumor of bone with EWSR1-NFATC2 gene fusion. Virchows Arch (2014) 0.75

EYA1 expression and subcellular localization in neuroblastoma and its association with prognostic markers. J Cancer Res Ther (Manch) (2016) 0.75

Noncoding RNA in drug resistant sarcoma. Oncotarget (2017) 0.75

Articles cited by this

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science (2005) 38.99

Chronic health conditions in adult survivors of childhood cancer. N Engl J Med (2006) 19.97

Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell (2007) 7.05

Cause-specific late mortality among 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst (2008) 5.05

Eya protein phosphatase activity regulates Six1-Dach-Eya transcriptional effects in mammalian organogenesis. Nature (2003) 3.72

Genome-wide analyses reveal properties of redundant and specific promoter occupancy within the ETS gene family. Genes Dev (2007) 3.56

Tyrosine dephosphorylation of H2AX modulates apoptosis and survival decisions. Nature (2009) 3.36

Development of Ewing's sarcoma from primary bone marrow-derived mesenchymal progenitor cells. Cancer Res (2005) 3.33

EWS/FLI-1 silencing and gene profiling of Ewing cells reveal downstream oncogenic pathways and a crucial role for repression of insulin-like growth factor binding protein 3. Mol Cell Biol (2004) 3.33

The eyes absent gene: genetic control of cell survival and differentiation in the developing Drosophila eye. Cell (1993) 3.08

Mesenchymal stem cell features of Ewing tumors. Cancer Cell (2007) 3.04

A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia. Blood (2001) 2.71

A human homologue of the Drosophila eyes absent gene underlies branchio-oto-renal (BOR) syndrome and identifies a novel gene family. Nat Genet (1997) 2.68

Six1 is required for the early organogenesis of mammalian kidney. Development (2003) 2.47

The role of Six1 in mammalian auditory system development. Development (2003) 2.22

Gene expression in Wilms' tumor mimics the earliest committed stage in the metanephric mesenchymal-epithelial transition. Am J Pathol (2002) 2.17

Microsatellites as EWS/FLI response elements in Ewing's sarcoma. Proc Natl Acad Sci U S A (2008) 2.06

Localized Ewing tumor of bone: final results of the cooperative Ewing's Sarcoma Study CESS 86. J Clin Oncol (2001) 2.01

Abrogation of the G2 cell cycle checkpoint associated with overexpression of HSIX1: a possible mechanism of breast carcinogenesis. Proc Natl Acad Sci U S A (1998) 1.86

EWS-FLI-1 modulates miRNA145 and SOX2 expression to initiate mesenchymal stem cell reprogramming toward Ewing sarcoma cancer stem cells. Genes Dev (2010) 1.81

The Ewing family of tumors. Ewing's sarcoma and primitive neuroectodermal tumors. Pediatr Clin North Am (1997) 1.79

MLL fusion proteins preferentially regulate a subset of wild-type MLL target genes in the leukemic genome. Blood (2011) 1.74

Six1 and Six4 homeoproteins are required for Pax3 and Mrf expression during myogenesis in the mouse embryo. Development (2005) 1.70

The oncogenic EWS-FLI1 protein binds in vivo GGAA microsatellite sequences with potential transcriptional activation function. PLoS One (2009) 1.63

EWS-Fli1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing's sarcoma and primitive neuroectodermal tumor cells. J Clin Invest (1997) 1.61

Six1 overexpression in ovarian carcinoma causes resistance to TRAIL-mediated apoptosis and is associated with poor survival. Cancer Res (2007) 1.60

Survival after recurrence of Ewing tumors: the St Jude Children's Research Hospital experience, 1979-1999. Cancer (2002) 1.60

Chemotherapy-induced tumor necrosis as a prognostic factor in localized Ewing's sarcoma of the extremities. J Clin Oncol (1997) 1.56

Cell cycle-regulated phosphorylation of the human SIX1 homeodomain protein. J Biol Chem (2000) 1.50

Gene amplification is a mechanism of Six1 overexpression in breast cancer. Cancer Res (2005) 1.49

Eya1 is required for the morphogenesis of mammalian thymus, parathyroid and thyroid. Development (2002) 1.49

The eyes absent family of phosphotyrosine phosphatases: properties and roles in developmental regulation of transcription. Annu Rev Biochem (2007) 1.40

Transcriptional coactivator Drosophila eyes absent homologue 2 is up-regulated in epithelial ovarian cancer and promotes tumor growth. Cancer Res (2005) 1.37

EYA4, a novel vertebrate gene related to Drosophila eyes absent. Hum Mol Genet (1999) 1.32

Eya2 is required to mediate the pro-metastatic functions of Six1 via the induction of TGF-β signaling, epithelial-mesenchymal transition, and cancer stem cell properties. Oncogene (2011) 1.30

Treatment of Ewing sarcoma family of tumors: current status and outlook for the future. Med Pediatr Oncol (2003) 1.29

Bone tumors: osteosarcoma and Ewing's sarcoma. Curr Opin Pediatr (2009) 1.28

The Eyes Absent phosphatase-transactivator proteins promote proliferation, transformation, migration, and invasion of tumor cells. Oncogene (2010) 1.28

Cloning and characterization of two vertebrate homologs of the Drosophila eyes absent gene. Genome Res (1997) 1.25

MicroRNA-708 induces apoptosis and suppresses tumorigenicity in renal cancer cells. Cancer Res (2011) 1.21

EWS-FLI1 induces developmental abnormalities and accelerates sarcoma formation in a transgenic mouse model. Cancer Res (2008) 1.17

Multiple aromatic side chains within a disordered structure are critical for transcription and transforming activity of EWS family oncoproteins. Proc Natl Acad Sci U S A (2007) 1.16

A novel oncogenic mechanism in Ewing sarcoma involving IGF pathway targeting by EWS/Fli1-regulated microRNAs. Oncogene (2011) 1.13

GLI1 is a central mediator of EWS/FLI1 signaling in Ewing tumors. PLoS One (2009) 1.10

Frequent methylation of eyes absent 4 gene in Barrett's esophagus and esophageal adenocarcinoma. Cancer Epidemiol Biomarkers Prev (2005) 1.03

Hsa-mir-145 is the top EWS-FLI1-repressed microRNA involved in a positive feedback loop in Ewing's sarcoma. Oncogene (2011) 1.03

Combined transcriptional and translational targeting of EWS/FLI-1 in Ewing's sarcoma. Clin Cancer Res (2006) 1.02

Novel method for high throughput DNA methylation marker evaluation using PNA-probe library hybridization and MALDI-TOF detection. Nucleic Acids Res (2006) 0.94

UNC-39, the C. elegans homolog of the human myotonic dystrophy-associated homeodomain protein Six5, regulates cell motility and differentiation. Dev Biol (2004) 0.92

Structure-based virtual screening approach to the discovery of novel inhibitors of eyes absent 2 phosphatase with various metal chelating moieties. Chem Biol Drug Des (2011) 0.89

Pleiotropic effects in Eya3 knockout mice. BMC Dev Biol (2008) 0.86

Articles by these authors

A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer. Cell (2003) 9.81

Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression. J Mammary Gland Biol Neoplasia (2010) 3.93

The role of HIV serostatus disclosure in antiretroviral medication adherence. AIDS Behav (2006) 2.56

The Six1 homeoprotein stimulates tumorigenesis by reactivation of cyclin A1. Proc Natl Acad Sci U S A (2004) 2.11

Interleukin 37 expression protects mice from colitis. Proc Natl Acad Sci U S A (2011) 2.06

The Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-beta signaling. J Clin Invest (2009) 2.01

Neural correlates of executive function in autistic spectrum disorders. Biol Psychiatry (2005) 1.88

SIX1 induces lymphangiogenesis and metastasis via upregulation of VEGF-C in mouse models of breast cancer. J Clin Invest (2012) 1.71

Hypoxia-inducible factor-1 alpha-dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa. Proc Natl Acad Sci U S A (2012) 1.70

Six1 expands the mouse mammary epithelial stem/progenitor cell pool and induces mammary tumors that undergo epithelial-mesenchymal transition. J Clin Invest (2009) 1.67

Six1 overexpression in ovarian carcinoma causes resistance to TRAIL-mediated apoptosis and is associated with poor survival. Cancer Res (2007) 1.60

A review of fronto-striatal and fronto-cortical brain abnormalities in children and adults with Attention Deficit Hyperactivity Disorder (ADHD) and new evidence for dysfunction in adults with ADHD during motivation and attention. Cortex (2011) 1.59

Diffuse intrinsic pontine tumors: a study of primitive neuroectodermal tumors versus the more common diffuse intrinsic pontine gliomas. J Neurosurg Pediatr (2012) 1.50

Breast cancer epithelial-to-mesenchymal transition: examining the functional consequences of plasticity. Breast Cancer Res (2011) 1.50

Gene amplification is a mechanism of Six1 overexpression in breast cancer. Cancer Res (2005) 1.49

The six family of homeobox genes in development and cancer. Adv Cancer Res (2008) 1.48

Characterization of two avian MHC-like genes reveals an ancient origin of the CD1 family. Proc Natl Acad Sci U S A (2005) 1.46

Estrogen receptor positive breast cancer metastasis: altered hormonal sensitivity and tumor aggressiveness in lymphatic vessels and lymph nodes. Cancer Res (2006) 1.43

Six1 overexpression in mammary cells induces genomic instability and is sufficient for malignant transformation. Cancer Res (2008) 1.35

Neural correlates of reward in autism. Br J Psychiatry (2008) 1.31

The neural correlates of cognitive time management: a review. Acta Neurobiol Exp (Wars) (2004) 1.30

Epithelial-mesenchymal transition and tumor suppression are controlled by a reciprocal feedback loop between ZEB1 and Grainyhead-like-2. Cancer Res (2013) 1.27

Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide. Breast Cancer Res (2014) 1.23

Spontaneous fusion with, and transformation of mouse stroma by, malignant human breast cancer epithelium. Cancer Res (2006) 1.21

Motor timing deficits in community and clinical boys with hyperactive behavior: the effect of methylphenidate on motor timing. J Abnorm Child Psychol (2003) 1.20

Performance of children with attention deficit hyperactivity disorder (ADHD) on a test battery of impulsiveness. Child Neuropsychol (2007) 1.20

Trials of teaching methods in basic life support (3): comparison of simulated CPR performance after first training and at 6 months, with a note on the value of re-training. Resuscitation (2002) 1.18

Epithelial-mesenchymal transition in development and cancer. Future Oncol (2009) 1.17

Homeoprotein Six1 increases TGF-beta type I receptor and converts TGF-beta signaling from suppressive to supportive for tumor growth. Cancer Res (2010) 1.16

Molecular pathways: targeting the TGF-β pathway for cancer therapy. Clin Cancer Res (2012) 1.15

Effects of age and sex on developmental neural networks of visual-spatial attention allocation. Neuroimage (2010) 1.10

Expression of Six1 in luminal breast cancers predicts poor prognosis and promotes increases in tumor initiating cells by activation of extracellular signal-regulated kinase and transforming growth factor-beta signaling pathways. Breast Cancer Res (2012) 1.10

Ets2 regulates colonic stem cells and sensitivity to tumorigenesis. Stem Cells (2011) 1.09

Skill acquisition and retention in automated external defibrillator (AED) use and CPR by lay responders: a prospective study. Resuscitation (2004) 1.08

Flt3 ligand expands CD103⁺ dendritic cells and FoxP3⁺ T regulatory cells, and attenuates Crohn's-like murine ileitis. Gut (2011) 1.06

Control of creatine metabolism by HIF is an endogenous mechanism of barrier regulation in colitis. Proc Natl Acad Sci U S A (2013) 1.04

The chemokine receptor CCR9 is required for the T-cell-mediated regulation of chronic ileitis in mice. Gastroenterology (2011) 1.03

Novel model of TH2-polarized chronic ileitis: the SAMP1 mouse. Inflamm Bowel Dis (2010) 1.01

Executive functions and memory abilities in children with 22q11.2 deletion syndrome. Aust N Z J Psychiatry (2010) 0.97

Retinoic acid attenuates ileitis by restoring the balance between T-helper 17 and T regulatory cells. Gastroenterology (2011) 0.97

A Decade in Banking Ewing Sarcoma: A Report from the Children's Oncology Group. Front Oncol (2013) 0.97

Structure-function analyses of the human SIX1-EYA2 complex reveal insights into metastasis and BOR syndrome. Nat Struct Mol Biol (2013) 0.96

Distinct TRAIL resistance mechanisms can be overcome by proteasome inhibition but not generally by synergizing agents. Cancer Res (2011) 0.96

A CMV DNA vaccine primes for memory immune responses to live-attenuated CMV (Towne strain). Vaccine (2009) 0.96

CCR3 Blockade Attenuates Eosinophilic Ileitis and Associated Remodeling. Am J Pathol (2011) 0.95

Transcriptional control of the cell cycle in mammary gland development and tumorigenesis. J Mammary Gland Biol Neoplasia (2004) 0.95

The SIX1-EYA transcriptional complex as a therapeutic target in cancer. Expert Opin Ther Targets (2015) 0.94

Transcriptional differences between normal and glioma-derived glial progenitor cells identify a core set of dysregulated genes. Cell Rep (2013) 0.93

Ectopic lymphoid tissue alters the chemokine gradient, increases lymphocyte retention and exacerbates murine ileitis. Gut (2012) 0.93

Biochemical and functional characterization of six SIX1 Branchio-oto-renal syndrome mutations. J Biol Chem (2009) 0.93

Best cases from the AFIP: fibrolamellar hepatocellular carcinoma. Radiographics (2008) 0.92

To blow or not to blow: a randomised controlled trial of compression-only and standard telephone CPR instructions in simulated cardiac arrest. Resuscitation (2003) 0.92

Loss of p53, rather than beta-catenin overexpression, induces survivin-mediated resistance to apoptosis in an esophageal cancer cell line. J Thorac Cardiovasc Surg (2010) 0.91

Parental stress associated with caring for children with Asperger's syndrome or autism. Pediatr Int (2008) 0.91

Disorder-specific dysfunctions in patients with attention-deficit/hyperactivity disorder compared to patients with obsessive-compulsive disorder during interference inhibition and attention allocation. Hum Brain Mapp (2011) 0.90

Effects of age and gender on neural networks of motor response inhibition: from adolescence to mid-adulthood. Neuroimage (2013) 0.90

MicroRNAs in Ewing Sarcoma. Front Oncol (2013) 0.90

Estrogen insensitivity in a model of estrogen receptor positive breast cancer lymph node metastasis. Cancer Res (2007) 0.89

High-LET radiation-induced response of microvessels in the Hippocampus. Radiat Res (2010) 0.88

Control of MicroRNA-21 expression in colorectal cancer cells by oncogenic epidermal growth factor/Ras signaling and Ets transcription factors. DNA Cell Biol (2012) 0.87

Vascular endothelial growth factor C promotes breast cancer progression via a novel antioxidant mechanism that involves regulation of superoxide dismutase 3. Breast Cancer Res (2014) 0.87

Characterization of the Six1 homeobox gene in normal mammary gland morphogenesis. BMC Dev Biol (2010) 0.86

Alpha-1-antitrypsin therapy ameliorates acute colitis and chronic murine ileitis. Inflamm Bowel Dis (2013) 0.86

The effectiveness of community day-long CBT-I workshops for participants with insomnia symptoms: a randomised controlled trial. J Sleep Res (2011) 0.85

Growth-promoting role of the miR-106a~363 cluster in Ewing sarcoma. PLoS One (2013) 0.84

TRAIL receptor signaling regulation of chemosensitivity in vivo but not in vitro. PLoS One (2011) 0.82

Intratumoral heterogeneity: Clonal cooperation in epithelial-to-mesenchymal transition and metastasis. Cell Adh Migr (2014) 0.82

Handhelds and HIPAA. Nurs Manage (2007) 0.81

Isolation and preliminary characterization of amino acid substitution mutations that increase the activity of the osmoregulated ProP protein of Salmonella enterica serovar Typhimurium. DNA Cell Biol (2012) 0.81

Eosinophils and IL-33 Perpetuate Chronic Inflammation and Fibrosis in a Pediatric Population with Stricturing Crohn's Ileitis. Inflamm Bowel Dis (2015) 0.81

Multigeneration assessment of nonylphenol and endosulfan using a model Australian freshwater fish, Melanotaenia fluviatilis. Environ Toxicol (2008) 0.80

Characterization of a divergent non-classical MHC class I gene in sharks. Immunogenetics (2003) 0.80

A comparison of strength and stretch interventions on active and passive ranges of movement in dancers: a randomized controlled trial. J Strength Cond Res (2013) 0.79

Specificity and prognostic validation of a polyclonal antibody to detect Six1 homeoprotein in ovarian cancer. Gynecol Oncol (2012) 0.79

A randomized pilot study comparing combination therapy plus enfuvirtide versus a treatment interruption followed by combination therapy plus enfuvirtide. Antivir Ther (2006) 0.78

Dynamic characteristics of 56Fe-particle radiation-induced alterations in the rat brain: magnetic resonance imaging and histological assessments. Radiat Res (2010) 0.78

Targeted inhibition of heat shock protein 90 suppresses tumor necrosis factor-α and ameliorates murine intestinal inflammation. Inflamm Bowel Dis (2014) 0.78

Very mild presentation in adult with classical cellular phenotype of ataxia telangiectasia. Mov Disord (2012) 0.78

Factors that predict discharge destination for patients in transitional care: a prospective observational cohort study. Aust Health Rev (2012) 0.78

Giant prolactinoma in an elderly man. J Am Geriatr Soc (2010) 0.75

Resistance patterns and response to entecavir intensification among HIV-HBV-coinfected adults with persistent HBV viremia. J Acquir Immune Defic Syndr (2011) 0.75

Neuroimaging assessment of memory-related brain structures in a rat model of acute space-like radiation. J Magn Reson Imaging (2009) 0.75

Pharmacokinetics of clarithromycin extended-release (ER) tablets in patients with AIDS. HIV Clin Trials (2005) 0.75

Developing expert clinical nurses: grow them, hold them and let them walk away. J Nurs Manag (2010) 0.75

Spontaneous intracerebral hemorrhage in a child with systemic hypertension and adrenal adenoma. Case report. J Neurosurg (2007) 0.75

Vascular compromise as a cause of sudden death in a pediatric patient with widely metastatic testicular germ cell tumor. J Pediatr Hematol Oncol (2009) 0.75

Taking Health Promotion to the Louisville Community. Ky Nurse (2016) 0.75